Maureen Dubreuil, MD, M.Sc.

Assistant Professor, Clinical Epidemiology Research & Training

Maureen Dubreuil
(617) 638-5180
650 Albany St Evans Biomed Research Ctr

Biography

Dr. Dubreuil is a rheumatologist in Boston, specializing in Spondyloarthritis. She works within the section of Clinical Epidemiology Unit at Boston University School of Medicine, where her research focuses on comorbidities and pharmacoepidemiology of spondyloarthritis. In 2013, she was awarded the Arthritis Foundation Clinical to Research Transition Award and 2016, she began work on a K23-funded project to study patient preferences, and the cost-effectiveness of treatment modalities for spondyloarthritis, to inform both clinical care and policy decisions. She is an Associate Member of the Spondyloarthritis Research and Treatment Network, and serves on the Education subcommittee, as well as the Early Career Investigator Subcommittee of the American College of Rheumatology.

Other Positions

  • Active Staff Hospital Privileges, Rheumatology, Boston Medical Center
  • VA Boston Healthcare System

Education

  • University of Connecticut School of Medicine, MD
  • Rochester Institute of Technology, BS

Publications

  • Published on 11/4/2017

    Nguyen UDT, Zhang Y, Lu N, Louie-Gao Q, Niu J, Ogdie A, Gelfand JM, LaValley MP, Dubreuil M, Sparks JA, Karlson EW, Choi HK. Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study. Ann Rheum Dis. 2017 Nov 04. PMID: 29102956.

    Read at: PubMed
  • Published on 10/13/2017

    Dalal D, Dubreuil M, Peloquin C, Neogi T, Zhang Y, Choi H, Felson D. Meloxicam and risk of myocardial infarction: a population-based nested case-control study. Rheumatol Int. 2017 Dec; 37(12):2071-2078. PMID: 29030657.

    Read at: PubMed
  • Published on 7/21/2017

    Jinno S, Lu N, Jafarzadeh SR, Dubreuil M. Trends of hospitalization for serious infections in patients with rheumatoid arthritis in the US between 1993 and 2013. Arthritis Care Res (Hoboken). 2017 Jul 21. PMID: 28732148.

    Read at: PubMed
  • Published on 7/11/2017

    Oza A, Lu N, Schoenfeld SR, Fisher MC, Dubreuil M, Rai SK, Zhang Y, Choi HK. Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study. Ann Rheum Dis. 2017 Oct; 76(10):1737-1742. PMID: 28698231.

    Read at: PubMed
  • Published on 7/1/2017

    Deodhar AA, Kumthekar A, Dubreuil M. Minimal disease activity in axial spondyloarthritis: the need of the hour and a proposal for development. Curr Opin Rheumatol. 2017 Jul; 29(4):293-297. PMID: 28376060.

    Read at: PubMed
  • Published on 7/1/2017

    Dubreuil M, Deodhar AA. Axial spondyloarthritis classification criteria: the debate continues. Curr Opin Rheumatol. 2017 Jul; 29(4):317-322. PMID: 28376062.

    Read at: PubMed
  • Published on 11/1/2016

    Jutkowitz E, Dubreuil M, Lu N, Kuntz KM, Choi HK. The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States. Semin Arthritis Rheum. 2017 Apr; 46(5):594-600. PMID: 27916277.

    Read at: PubMed
  • Published on 6/23/2016

    Zhang Y, Lu N, Peloquin C, Dubreuil M, Neogi T, AviƱa-Zubieta JA, Rai SK, Choi HK. Improved survival in rheumatoid arthritis: a general population-based cohort study. Ann Rheum Dis. 2017 Feb; 76(2):408-413. PMID: 27338777.

    Read at: PubMed
  • Published on 6/1/2016

    Jinno S, Hasegawa K, Neogi T, Goto T, Dubreuil M. Trends in Emergency Department Visits and Charges for Gout in the United States between 2006 and 2012. J Rheumatol. 2016 Aug; 43(8):1589-92. PMID: 27252429.

    Read at: PubMed
  • Published on 3/15/2016

    Lee T, Lu N, Felson DT, Choi HK, Dalal DS, Zhang Y, Dubreuil M. Use of non-steroidal anti-inflammatory drugs correlates with the risk of venous thromboembolism in knee osteoarthritis patients: a UK population-based case-control study. Rheumatology (Oxford). 2016 Jun; 55(6):1099-105. PMID: 26983451.

    Read at: PubMed

View 11 more publications: View full profile at BUMC

View all profiles